OTC:RSCF
REFLECT SCIENTIFIC, INC.
A small-cap OTC technology firm generating $1.1M in revenue while posting a $459k net loss due to high administrative and R&D expenses.
Key Metrics
Investment Thesis
Bull Case
Investors might view RSCF as a turnaround opportunity given its substantial paid-in capital of $20.3M which provides a cushion against current losses.", "The company's focus on research and development with $29k in spend could lead to future product differentiation if successful commercialization occurs.", "Significant non-operating income of $8.5k indicates potential for hidden value or strategic partnerships not fully reflected in core operations.
Bear Case
Revenue has contracted sharply from $2.0M in 2022 to $1.1M in 2023 while losses have deepened from a profit to -$459k.", "Negative cash flow of nearly $104k combined with a massive retained earnings deficit of -$19.3M creates significant downside risk for shareholders.", "Operating expenses are disproportionately high relative to revenue, suggesting fundamental issues in cost management or business model scalability.
About REFLECT SCIENTIFIC, INC.
REFLECT SCIENTIFIC (RSCF) is a technology-focused entity operating within the scientific research or specialized software sectors, serving niche markets with proprietary solutions. The company leverages significant intangible assets, including substantial goodwill and long-term lease structures, to support its operational framework. Recent financial reporting indicates a shift from profitability to a net loss driven by elevated operating costs relative to revenue.
Analysis
Management Discussion
Management faces a critical challenge as the company recorded a net loss of $459k, driven by operating expenses that surpassed revenue, resulting in negative cash flow from operations.", "While the company maintains positive current assets of $2.4M against liabilities of $776k, the burn rate and large inventory increase of $175k warrant close scrutiny regarding working capital efficiency.", "The reliance on non-cash adjustments totaling -$174k suggests a need to improve core operational profitability before focusing solely on balance sheet restructuring.
Industry Overview
The scientific and technology services sector is often characterized by high R&D requirements and volatile revenue cycles dependent on contract research or software licensing deals.", "Companies in this space frequently utilize share-based compensation to attract talent, which aligns with RSCF's financial structure but can mask true cash burn rates.", "Market consolidation is common in niche scientific fields, meaning small players like RSCF must demonstrate clear competitive advantages to survive long-term.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 |
|---|---|---|
| Revenue | $2.0M | $1.1M |
| Cost of Revenue | $822.1K | $483.7K |
| Gross Profit | $1.2M | $596.4K |
| Operating Expenses | $1.1M | $1.1M |
| Operating Income | $90.1K | $-467.3K |
| R&D | $73.4K | $29.5K |
| G&A | $419.6K | $388.6K |
| Stock-Based Comp | $27.5K | $55.0K |
| Amortization | $56.2K | $61.5K |
| Other OpEx | $636.0K | $645.5K |
| Non-Operating Income | $0 | $8.6K |
| Pre-Tax Income | $90.1K | $-458.7K |
| Income Tax | $702 | $312 |
| Continuing Ops | $89.4K | $-459.0K |
| Discontinued Ops | $0 | $0 |
| Net Income | $89.4K | $-459.0K |
| Minority Interest | $0 | $0 |
| Net to Common | $89.4K | $-459.0K |
| Metric | 2022 | 2023 |
|---|---|---|
| Current Assets | $2.3M | $2.4M |
| Accounts Receivable | $129.3K | $108.2K |
| Inventory | $797.4K | $972.3K |
| Other Current Assets | $1.4M | $1.3M |
| Long-Term Assets | $117.4K | $298.8K |
| Goodwill | $60.0K | $60.0K |
| Operating Leases | $54.3K | $235.7K |
| Other LT Assets | $3.1K | $3.1K |
| Total Assets | $2.4M | $2.7M |
| Current Liabilities | $149.6K | $596.4K |
| Current Leases | $57.4K | $62.7K |
| Other Current Liab | $92.2K | $533.7K |
| Long-Term Liabilities | $0 | $180.0K |
| LT Operating Leases | — | $180.0K |
| Other LT Liab | — | $0 |
| Total Liabilities | $149.6K | $776.3K |
| Shareholders' Equity | $2.3M | $1.9M |
| Paid-In Capital | $20.3M | $20.3M |
| Retained Earnings | $-18.8M | $-19.3M |
| Total L&E | $2.4M | $2.7M |
| Metric | 2022 | 2023 |
|---|---|---|
| Net Income (CFO) | $89.4K | $-459.0K |
| Non-Cash Adjustments | $-252.5K | $-174.1K |
| Working Capital Changes | $71.1K | $529.2K |
| Cash from Operations | $-92.0K | $-104.0K |
| FX Effect | $0 | $0 |
| Net Change in Cash | $-92.0K | $-104.0K |
| Beginning Cash | $1.5M | $1.4M |
| Ending Cash | $1.4M | $1.3M |
Frequently Asked Questions
How does REFLECT SCIENTIFIC, INC. make money?
The company's revenue streams appear concentrated in core scientific or software services, supported by significant non-cash adjustments and share-based compensation, with operating expenses exceeding revenue by over $600k.
What are the main risks for RSCF?
Persistent negative cash flow from operations of -$104k indicating potential liquidity constraints without external financing.", "Elevated operating expenses of $1.1M against only $1.1M in revenue suggests an unsustainable loss-making model currently.", "High retained earnings deficit of -$19.3M signals historical financial distress that must be addressed to restore solvency.", "Limited market capitalization and OTC listing status may restrict access to broader investment pools and increase volatility.
What is RSCF's competitive advantage?
Significant intangible asset base including $60k in goodwill and capitalized long-term operating lease assets totaling $235k.", "Substantial paid-in capital of $20.3M providing a financial buffer for future strategic initiatives.", "Ability to utilize share-based compensation to align executive interests with shareholder value while managing cash burn.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.